Director at $AERG sells 10,000 shares in insider sale

Bradford Thomas Adamczyk, a director at $AERG, completed the sale of 10,000 shares from the company on the 7th of January, 2026, for an estimated value of $17,700. This transaction was disclosed through an SEC filing obtained recently. This particular sale accounted for around 1.5% of the director’s holdings of this specific category of stock within the company. Subsequent to this sale, the director now retains possession of 671,482 shares within this $AERG stock category.

There has been notable insider trading activity within the $AERG company over the past 6 months, with insiders executing transactions a total of 21 times. Among these transactions, there have been no purchases and 21 sales completed. Specifically, Bradford Thomas Adamczyk has been actively involved in these trades with no purchases, but successfully executing 6 sales transactions, selling off a sum of 60,000 shares estimated at a value of $108,000. Similarly, Christopher Wayne Donaghey, the President, CEO, and Principal AO, has made no purchases while undertaking 6 sales transactions, selling off 50,000 shares for a sum of approximately $90,877. The CEO Emeritus, Gregory James Quarles, has carried out 4 sales amounting to 40,000 shares valued at $78,200. Furthermore, Stephen William McCahon, the Chief Science Officer, completed 5 sales transactions disposing of 40,000 shares for an approximated value of $65,189.

For investors keeping a keen eye on insider transactions, the insider trading dashboard provided by Quiver Quantitative offers a comprehensive tool for tracking these moves. In contrast, concerning hedge fund activity, there haven’t been any institutional investors adding or decreasing their shares within the $AERG stock in the most recent quarter analyzed. Notably, Game Plan Financial Advisors, LLC, added 0 shares to their portfolio in Q3 2025, reflecting a neutral position in terms of trades.

It is essential to note that the dissemination of this information does not constitute financial advice, hence prudent considerations and due diligence are advisable when making investment decisions. For further clarification, it is advised to refer to the disclaimers provided by Quiver Quantitative.